TUBERSOL DIN 00317268
Status: Marketed
Holder: SANOFI VACCINES CANADA LTD.
Available to quote
Health Canada record
| Active ingredient(s) | PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN 5 TUB |
|---|---|
| Dosage form | Solution |
| Route | Intradermal |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | V04CF01 TUBERCULIN |
| Original market date | 31-Dec-1975 |
| Current status date | 10-Nov-2006 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sanofi Vaccines Canada Ltd. — licence 101420, currently licensed, last inspection rating C (2026-02-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00316377 | TUBERCULIN PPD (MANTOUX) | AVENTIS PASTEUR LIMITED | Liquid | PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN 1 TUB | Cancelled Post Market |
| 00317233 | TUBERCULIN PPD (MANTOUX) | AVENTIS PASTEUR LIMITED | Liquid | PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN 250 TUB | Cancelled Post Market |